论文部分内容阅读
目的:分析研究阿奇霉素对急性社区获得性下呼吸道感染的临床疗效。方法:随机选取2013年3月-2015年3月本院接诊的88例急性社区获得性下呼吸道感染患者作为研究对象,按照数字表法进行随机分组,对照组及观察组各44例;对照组采取左氧氟沙星进行临床治疗,观察组采取阿奇霉素进行临床治疗。结果:采用统计学软件对比两组患者的临床治疗总有效率、各项临床症状的消失时间以及不良反应发生几率,观察组均明显优于对照组(P<0.05)。结论:阿奇霉素对急性社区获得性下呼吸道感染具有较为理想的临床治疗效果,其可有效缩短患者各项症状的消失时间,提高患者的康复速度、降低患者痛苦,同时该药物的不良反应发生几率相对较低,临床应用安全性较高,故值得在急性社区获得性下呼吸道感染的临床治疗工作中推广应用。
Objective: To analyze the clinical effect of azithromycin on acute community-acquired lower respiratory tract infection. Methods: From March 2013 to March 2015, 88 patients with acute community-acquired lower respiratory tract infection admitted to our hospital were randomly selected and divided into two groups according to the digital table method: control group and observation group, 44 cases in each group. Group to take levofloxacin clinical treatment, the observation group to take azithromycin clinical treatment. Results: The total effective rate of clinical treatment, the disappearance time of various clinical symptoms and the incidence of adverse reactions in the two groups were compared by statistical software. The observation group was significantly better than the control group (P <0.05). Conclusion: Azithromycin has an ideal clinical therapeutic effect on acute community-acquired lower respiratory tract infection, which can effectively shorten the disappearance time of various symptoms, improve the recovery rate of patients and reduce the pain of patients, and the incidence of adverse reactions of the drug is relatively Lower safety and clinical application of high, it is worth in the acute community-acquired lower respiratory tract infection in clinical treatment work to promote the application.